BrightPath Biotherapeutics Co.,Ltd. shares rose ¥4 from the previous day to trade at ¥61. After-hours PTS trading was at ¥57, ¥4 below the previous close, with trading volume of approximately 2.77 million shares.
BrightPath Biotherapeutics Co.,Ltd. shares are trading at ¥61, up ¥4 from the previous day. During daytime trading, the shares appeared to move mainly around ¥61.
In after-hours PTS trading, the shares were at ¥57, ¥4 below the previous close. Trading price movements have continued to alternate between sharp rebounds and sharp declines.
The next earnings announcement date has not yet been scheduled. According to the summary of the earnings report, for the first quarter of the fiscal year ending March 2027, the company posted an operating loss of ¥547 million, revenue of ¥11,000, and a quarterly net loss of ¥531 million. Full-year net loss is projected at approximately ¥1.95 billion.
Development progress, including the start of clinical trials in the United States, is cited as a key point to monitor for future performance, while financial pressure and the risk of development delays have also been noted.